Clarithromycin Prices

Clarithromycin Prices June 2023

In the second quarter of 2023, the price of the clarithromycin the North America reached 257,700 USD/MT by June. Similarly, in Asia Pacific, the clarithromycin prices hit 203,200 USD/MT in the same month. Europe also saw clarithromycin prices reaching 260,500 USD/MT during Q2 2023.

Clarithromycin Price Trend, Market Analysis, and News

IMARC’s newly published report, titled “Clarithromycin Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of clarithromycin pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.

It encompasses an in-depth review of spot price of clarithromycin at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of clarithromycin price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.

The report examines the elements influencing clarithromycin price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.

Clarithromycin Market Analysis

The global clarithromycin market size reached US$ 1.5 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 2.3 Billion, at a projected CAGR of 4.50% during 2023-2032.

• The rising incidence of respiratory infections across the world is significantly driving the demand for clarithromycin. Conditions like bronchitis, pneumonia, and sinusitis have seen a significant rise due to the factors like pollution, smoking, and growing geriatric population that is more vulnerable to such infections. According to a data published by the World Health Organization, seasonal influenza affects around a billion people yearly along with 3 million to 5 million experiencing severe illness. It leads to 290,000 to 650,000 respiratory deaths every year. In developing countries, 99% of deaths from influenza related lower respiratory tract infections occur in children under 5. Clarithromycin is a broad-spectrum macrolide antibiotic which is highly effective in treating these bacterial infections. Its ability to target a wide array of pathogen makes it a highly sought after choice among healthcare providers, thereby propelling its market growth.
• Rising investments by pharmaceutical companies in research and development (R&D) significantly propels the clarithromycin market growth. These investments mainly focus on discovering new therapeutic indications and enhancing existing formulations to improve its efficacy and patient compliance. For instance, in 2022, Pfizer invested $120 million in its Kalamazoo Facility to produce its COVID-19 oral treatment PAXLOVID. In line with this, the ongoing research aims to combat antibiotic resistance, further ensuring clarithromycin remains a viable treatment option for respiratory infections. These innovations not only enhance the drug’s clinical utility, but also opens new opportunities for the market growth.
• The growing geriatric population is also contributing to the rising demand for clarithromycin. As people age, their immune systems become less robust, which makes them more susceptible to respiratory infection and bacterial infections. According to data published by the World Health Organization, by year 2030, 1 in 6 people across the world will be aged 60 years or above. The proportion of global population over 60 years old is expected to nearly double from 12% in 2015 to 22% in 2050 with 2.1 billion people aging over 60 years or above by 2050. The elderly are at higher risk for conditions like pneumonia and bronchitis, which often require antibiotic treatment. Clarithromycin is a broad-spectrum antibiotic which is frequently prescribed for these infections due to its effectiveness against a wide array of pathogens. The rising number of elderly individuals across the world drives the demand for reliable antibiotics like clarithromycin to manage these health challenges effectively.

Clarithromycin News

The report covers the latest developments, updates, and trends impacting the global clarithromycin market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in clarithromycin production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the clarithromycin price trend.

Latest developments in the clarithromycin industry:

• In 2024, Abbott launched GLP Systems Track, an innovative automation solution to support high-volume laboratory needs in India. The system, installed in Chennai, Bengaluru, Ahmedabad, and Srinagar, reduces manual steps by 80%, minimizing errors and improving turnaround time. The technology aims to increase testing capabilities, reduce operational costs, and enhance workflow and productivity, ultimately improving patient care and safety.
• In 2024, AbbVie and Gilgamesh Pharmaceuticals collaborated to develop next-generation therapies for psychiatric disorders. The collaboration will focus on leveraging AbbVie's psychiatry expertise and Gilgamesh's innovwkative research platform to discover novel neuroplastogens. Under the agreement, AbbVie will lead development and commercialization activities if the option is exercised. Gilgamesh will receive an upfront payment of $65 million and is eligible for up to $1.95 billion in fees and milestones, as well as royalties from net sales.

Product Description

Clarithromycin is a broad-spectrum macrolide antibiotic commonly used to treat various bacterial infections. It is particularly effective against respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as skin infections, ear infections, and Helicobacter pylori-associated peptic ulcers. Clarithromycin works by inhibiting bacterial protein synthesis, thereby stopping the growth and reproduction of bacteria. Its mechanism of action involves binding to the 50S ribosomal subunit of the bacteria, blocking the translocation of peptides. The antibiotic is available in both immediate-release and extended-release formulations, allowing flexibility in dosing and enhancing patient compliance. Clarithromycin is also used in combination with other medications to treat specific infections, like H. pylori eradication in peptic ulcer disease. It is generally well-tolerated, but potential side effects can include gastrointestinal disturbances, headaches, and taste disturbances. Due to its efficacy and versatility, clarithromycin is a widely prescribed antibiotic in clinical practice.

Regional Coverage

The report provides a detailed analysis of the clarithromycin market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the clarithromycin price trend. 

Global Clarithromycin Price

The report offers a holistic view of the global clarithromycin pricing trends in the form of clarithromycin price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of clarithromycin but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.

The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed clarithromycin demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.

Europe Clarithromycin Price

European clarithromycin prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.

This analysis can be extended to include detailed clarithromycin price information for a comprehensive list of countries.

North America Clarithromycin Price

The analysis of clarithromycin prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.

Specific clarithromycin historical data within the United States and Canada can also be provided.

Middle East and Africa Clarithromycin Price

The report explores the clarithromycin pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.

In addition to region-wise data, information on clarithromycin prices for countries can also be provided.

Asia Pacific Clarithromycin Price

The clarithromycin pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.

This clarithromycin price analysis can be expanded to include a comprehensive list of countries within the region.

Latin America Clarithromycin Price

The analysis of clarithromycin prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.

This comprehensive review can be extended to include specific countries within the region.

Report Coverage

Key Benefits for Stakeholders:

• IMARC’s report presents a detailed analysis of clarithromycin pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
• The study examines factors affecting clarithromycin price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
• The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
• IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The clarithromycin price charts ensure our clients remain at the forefront of the industry.